In Part II of this blog series we look at recent transactions in the arena of contract research organization, with a particular focus on private equity investing in CROs.

In one recent example, prescription drug data-mining company IMS Health acquired

Continue Reading Private Equity Opportunities in Contract Research Organizations (CROs): Part II

Contract research organizations (CRO) provide research services support for the biotechnology, medical device and pharmaceutical industries on a contractual basis. They offer such services as preclinical and clinical research, clinical trials management, biopharmaceutical development and pharmacovigilance. CROs run the gamut

Continue Reading Private Equity Opportunities in Contract Research Organizations (CROs): Part I

During recent months, private equity firms have been actively selling and buying dental practices, which some investors believe is a relatively stable and recession-proof health-care arena. With an aging population requiring more dental work, minimal government intervention and mostly private-pay

Continue Reading Dental Investing Filling Need for PE Investing – Part II

            A few weeks ago, McGuireWoods hosted our 8th Annual Healthcare & Life Sciences Private Equity & Finance Conference along with co-sponsor McGladrey.  The Hon. Bill Frist gave the keynote address.  It was a real treat to

Continue Reading Value-Based Healthcare Solutions: A Prescription for Investors in an Era of Healthcare Reform